Details for Patent: 4,983,598
✉ Email this page to a colleague
Summary for Patent: 4,983,598
Title: | Pharmaceutical composition containing diltiazem and angiotensin-converting enzyme inhibitor |
Abstract: | Compositions of diltiazem and angiotensin-converting enzyme inhibitor useful for the treatment of hypertension, cardiac insufficiency and coronary insufficiency. |
Inventor(s): | Cavero; Icilio (Creteil, FR), Elkik; Francois (Paris, FR), Hicks; Peter (Cachan, FR), Muller; Jean-Claude (Morsang S/Orge, FR) |
Assignee: | Synthelabo (Paris, FR) |
Application Number: | 07/195,151 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 4,983,598
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 4,983,598
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
France | 86 16138 | Nov 20, 1986 |
International Family Members for US Patent 4,983,598
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 54253 | ⤷ Sign Up | |||
Australia | 596712 | ⤷ Sign Up | |||
Australia | 8140787 | ⤷ Sign Up | |||
Canada | 1302268 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |